MetLife, Inc. (MET) Balance Sheet

The asset growth is primarily funded by liability increases, with total liabilities up 11.2% from $648.2B to $720.3B over the same period. Equity has been range-bound between $27.3B and $30.9B over the past ten quarters, suggesting that capital generation is being offset by dividends and buybacks. This pattern implies that the balance sheet is expanding through increased policyholder reserves and debt, rather than organic capital accumulation, which may warrant monitoring of capital adequacy.

The lack of meaningful investment data prevents a thorough assessment of portfolio quality, duration, or unrealized loss positions. However, the prior cash flow analysis indicated net investment purchases of $6.5B in Q2 2026, suggesting active deployment. Given the large general account, investors should monitor the mix between fixed income and equities, as rising rates may have created unrealized losses that could pressure equity in future periods.

The loss ratio in Q2 2026 is the highest in the ten-quarter period, well above the 70-75% range seen in most prior quarters. This suggests that claims costs are accelerating, possibly due to inflationary pressures in dental and disability lines. While the combined ratio remains below 100%, the elevated loss ratio may indicate that reserves are being depleted, and future favorable development could be limited. Investors should monitor whether this is a seasonal blip or a trend.

The equity-to-assets ratio has declined from 4.2% in Q4 2024 to 3.6% in Q2 2026, reflecting the flat equity base against growing assets. This suggests that the company is relying more on leverage to fund growth, which could limit its capacity for buybacks or M&A. While statutory capital ratios are not disclosed, the trend in GAAP equity warrants attention, especially given the reported EPS miss and potential CRE impairments.

The absence of cash balance data limits direct liquidity assessment, but the robust operating cash flow relative to net income suggests that the company generates sufficient cash to meet policyholder obligations. The prior cash flow analysis noted that dividends and buybacks consumed 51% of operating cash flow, leaving a reasonable cushion. However, the large investment purchases may reduce liquid assets, so monitoring the cash position in future filings is advisable.